Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.26) per share. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year.
BTIG Downgrades Renovacor to Neutral
BTIG analyst Yun Zhong downgrades Renovacor (AMEX:RCOR) from Buy to Neutral.